Tygacil Approval History
FDA Approved: Yes (First approved June 15, 2005)
Brand name: Tygacil
Generic name: tigecycline
Dosage form: Injection
Company: Wyeth Pharmaceuticals
Treatment for: Skin and Structure Infection, Intraabdominal Infection, Pneumonia
Tygacil (tigecycline) is a glycylcycline antibacterial indicated for the treatment of complicated skin and skin structure infections, complicated intra-abdominal infections and community-acquired bacterial pneumonia in adults.
Development History and FDA Approval Process for Tygacil
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.